OABI Q3 2022 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$221M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+10.1% YoY

Gross Profit

$2M34.8% margin

Operating Income

-$15M-218.8% margin

Net Income

-$13M-182.3% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

-4.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$8M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$238M

Total Liabilities

$14M

Stockholders' Equity

$223M

Cash & Equivalents

$19,847

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$6M	+10.1%
Gross Profit	$2M	$6M	-61.6%
Operating Income	-$15M	-$10M	-54.2%
Net Income	-$13M	-$8M	-59.6%